What's going on in today's session: S&P500 gap up and gap down stocks
By Mill Chart
Last update: Apr 29, 2024
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| BEN | -3.84% | Today, FRANKLIN RESOURCES INC's (NYSE:BEN) stock experienced a 3.84% fall to $24.03 with a 6.13% gap. yesterday the company released their earnings. A press release (Franklin Resources, Inc. Announces Second Quarter Results) was released earlier today. |
| DLTR | -3.41% | DOLLAR TREE INC's (NASDAQ:DLTR) shares declined by 3.41% to $117.58, showing a 4.43% gap in today's session. In the last year the share price dropped with 20.8%. |
| RMD | -2.59% | Unfortunate news for RESMED INC's (NYSE:RMD) stock! It registered a 2.59% decline to $212.41 in today's session, accompanied by a 3.75% gap. In the last 6 months the stock gained 61.95%. |
| GOOGL | -2.23% | Unfortunate news for ALPHABET INC-CL A's (NASDAQ:GOOGL) stock! It registered a 2.23% decline to $168.12 in today's session, accompanied by a 4.37% gap. The stock is trading 40.75% higher than 6 months ago. |
| GOOG | -2.19% | Today, ALPHABET INC-CL C's (NASDAQ:GOOG) stock experienced a 2.19% fall to $169.88 with a 4.26% gap. Shareholders saw the stock price going 40.75% higher is the past 6 months. |
| LUV | -2.07% | SOUTHWEST AIRLINES CO's (NYSE:LUV) shares fell 2.07% to $26.47 with a gap of 4.15%. In the last 6 months the share price increased with 20.99%. |
| META | -1.94% | Today, META PLATFORMS INC-CLASS A's (NASDAQ:META) stock experienced a 1.94% fall to $434.68 with a 3.12% gap. In the last 6 months the stock gained 49.39%. |
| NEM | -1.92% | NEWMONT CORP's (NYSE:NEM) stock price is declining with 1.92% to a price of $41.91 with a gap of 4.31%. Shareholders saw the stock price going 24.91% higher in the past 3 months. |
| INTC | -1.77% | INTEL CORP's (NASDAQ:INTC) shares suffered a 1.77% decline to $31.32 during Monday's session, accompanied by a 3.63% gap. The stock is trading 27.82% lower than a month ago. |
| WDC | -1.72% | WESTERN DIGITAL CORP's (NASDAQ:WDC) shares fell 1.72% to $70.13 with a gap of 3.61%. The stock is trading 22.55% higher than 3 months ago. |
Our gap down stocks screener will show you the full list.
RESMED INC
NYSE:RMD (5/17/2024, 7:23:49 PM)
After market: 218.57 0 (0%)218.57
-1.4 (-0.64%)
RMD News
3 days ago - ResMed Inc.ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP TherapyATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy ...
3 days ago - MatrixCareMatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data AccessThe alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes.
12 days ago - ResMed Inc.ResMed Announces Participation in the RBCCM Global Healthcare Conference
18 days ago - Market News VideoResMed Now #262 Largest Company, Surpassing Discover Financial Services
19 days ago - Investor's Business DailyInspire Medical Systems Stock Sees IBD RS Rating Rise To 78On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
20 days ago - ChartmillWhat's going on in today's session: S&P500 moversWhat's going on in today's session: S&P500 movers
20 days ago - ChartmillWhat's going on in today's session: S&P500 gap up and gap down stocksLet's have a look at the S&P500 gap up and gap down stocks in today's session.
20 days ago - Market News VideoS&P 500 Movers: RMD, TSLA
23 days ago - The Motley FoolWhy ResMed Stock Is Soaring TodayInvestors liked the healthcare technology company's latest quarterly update.
23 days ago - Market News VideoS&P 500 Movers: INTC, RMD
23 days ago - Investor's Business DailyResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss WoesResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss drugs could help diagnosis rates.
